Huakang Biomedical Holdings Company Limited Financial Overview
Huakang Biomedical Holdings Company Limited's market cap is currently HK$216.50M. The company's EPS TTM is HK$-0.005; its P/E ratio is -41.18; Huakang Biomedical Holdings Company Limited is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
